Yifeng Pharmacy Chain Co., Ltd.
603939
Kedudukan dalam Saham
#3625
Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical... Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical goods across China. As of March 31, 2021, the company oversaw an expansive network of approximately 6,279 retail pharmacies. These establishments are strategically situated throughout various significant Chinese provinces and municipalities, including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The firm was founded in 2001 and has its primary corporate office located in Changsha, China.
Harga Saham
$3.85
Modal Pasaran
$4.66B
Perubahan (1 hari)
0.20%
Perubahan (1 tahun)
9.14%
Negara
CN
Perdagangan Yifeng Pharmacy Chain Co., Ltd. (603939)
Kategori
Healthcare
Hasil untuk Yifeng Pharmacy Chain Co., Ltd. (603939)
Hasil pada Jun 2026 TTM: $3.60B
Menurut laporan kewangan terkini daripada Yifeng Pharmacy Chain Co., Ltd., hasil semasa syarikat (TTM) ialah $3.60B. Pada tahun 2023, syarikat memperoleh hasil sebanyak $3.19B peningkatan berbanding hasil pada tahun 2022 iaitu $2.88B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Yifeng Pharmacy Chain Co., Ltd. dari 2011 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $3.60B | 9.20% |
| 2024 | $3.30B | 3.31% |
| 2023 | $3.19B | 10.69% |
| 2022 | $2.88B | 19.56% |
| 2021 | $2.41B | 19.84% |
| 2020 | $2.01B | 36.34% |
| 2019 | $1.48B | 46.85% |
| 2018 | $1.00B | 36.01% |
| 2017 | $738.87M | 37.40% |
| 2016 | $537.76M | 22.72% |
| 2015 | $438.19M | 21.70% |
| 2014 | $360.06M | 21.05% |
| 2013 | $297.46M | 20.49% |
| 2012 | $246.88M | 27.14% |
| 2011 | $194.18M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $2.54B | -29.55% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $830.81M | -76.92% |
US
|
|
| - | - |
IT
|
